📰 Boxed Warning News
Page 24 - Boxed Warning News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Boxed Warning. Real-time updates on events, politics, business and more.
July 1, 2023
Autoinjector recognized by the Arthritis Foundation with Ease of Use Certification Individualized patient support program “HADLIMA For You” available including co-pay support Designed to improve access and affordability for patients and the US health care system
June 26, 2023
The FDA has approved Litfulo (ritlecitinib) for the treatment of severe alopecia areata in adults and adolescents 12 years and older.
June 23, 2023
(RTTNews) - Gilead Sciences Inc. (GILD) said that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
June 23, 2023
23.06.2023 - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for Trodelvy (sacituzumab govitecan) as monotherapy for the ...
June 22, 2023
The FDA has approved Columvi®® (glofitamab-gxbm) for the treatment of adult patients with R/R DLBCL after ≥2 or greater lines of systemic therapy.
June 20, 2023
LUPKYNIS® achieved significantly earlier reductions in UPCR and significantly higher renal response rates in lupus nephritis patients with high proteinuria, compared to patients treated with... | June 20, 2023
June 16, 2023
The FDA has approved Columvi®® (glofitamab-gxbm) for the treatment of adult patients with R/R DLBCL after ≥2 or greater lines of systemic therapy.
June 15, 2023
/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that two scientific posters detailing...
June 13, 2023
/PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV) today announced the 20 incredible women entrepreneurs who will receive funding and...
June 13, 2023
Brixadi (buprenorphine) is approved for patients with moderate to severe OUD who are already taking or have initiated transmucosal buprenorphine.